Total Payments
$12,181
2024 Payments
$2,520
Companies
37
Transactions
745
Medicare Patients
12,875
Medicare Billing
$1.2M
Payment Breakdown by Category
Food & Beverage$12,127 (99.6%)
Education$53.84 (0.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,127 | 742 | 99.6% |
| Education | $53.84 | 3 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,410 | 100 | $0 (2024) |
| ABBVIE INC. | $1,397 | 100 | $0 (2024) |
| Mylan Specialty L.P. | $989.59 | 53 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $916.99 | 53 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $901.69 | 51 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $830.39 | 71 | $0 (2021) |
| GlaxoSmithKline, LLC. | $596.40 | 30 | $0 (2024) |
| Lilly USA, LLC | $495.56 | 38 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $488.75 | 36 | $0 (2024) |
| Amgen Inc. | $436.56 | 23 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,520 | 124 | Supernus Pharmaceuticals, Inc. ($428.88) |
| 2023 | $2,084 | 136 | ABBVIE INC. ($391.97) |
| 2022 | $1,835 | 118 | ABBVIE INC. ($355.66) |
| 2021 | $1,822 | 134 | AbbVie Inc. ($248.14) |
| 2020 | $1,369 | 92 | Sunovion Pharmaceuticals Inc. ($288.39) |
| 2019 | $833.90 | 55 | Mylan Specialty L.P. ($288.31) |
| 2018 | $944.09 | 48 | GlaxoSmithKline, LLC. ($167.99) |
| 2017 | $772.42 | 38 | SANOFI-AVENTIS U.S. LLC ($228.33) |
All Payment Transactions
745 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Oncology | ||||||
| 12/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $124.97 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: Cardio-renal | ||||||
| 12/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Diabetes | ||||||
| 12/07/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $9.13 | General |
| Category: Obesity | ||||||
| 12/05/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: PAIN | ||||||
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/26/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: PAIN | ||||||
| 11/22/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Oncology | ||||||
| 11/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: Cardio-renal | ||||||
| 11/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: Obesity | ||||||
| 11/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: DIABETES | ||||||
| 11/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: PSYCHIATRY | ||||||
| 11/05/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Oncology | ||||||
| 10/29/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $23.15 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/24/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $6.57 | General |
| Category: PAIN | ||||||
| 10/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $9.31 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $1.25 | General |
| Category: PAIN | ||||||
| 10/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Cardio-renal | ||||||
| 10/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.49 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 39 | 3,541 | 7,276 | $971,213 | $310,600 |
| 2022 | 34 | 2,694 | 6,038 | $885,181 | $273,285 |
| 2021 | 36 | 3,170 | 6,251 | $875,731 | $270,916 |
| 2020 | 33 | 3,470 | 6,144 | $835,644 | $333,627 |
Total Patients
12,875
Total Services
25,709
Medicare Billing
$1.2M
Procedure Codes
144
All Medicare Procedures & Services
144 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 463 | 968 | $154,880 | $55,131 | 35.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 320 | 320 | $114,394 | $38,368 | 33.5% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 128 | 1,080 | $108,000 | $34,401 | 31.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 313 | 477 | $132,606 | $34,354 | 25.9% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 131 | 1,117 | $134,040 | $33,411 | 24.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 140 | 155 | $55,332 | $14,828 | 26.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 181 | 217 | $42,087 | $13,087 | 31.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 100 | 216 | $32,433 | $12,595 | 38.8% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 47 | 122 | $27,537 | $9,586 | 34.8% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 331 | 331 | $6,620 | $5,558 | 84.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 328 | 328 | $6,560 | $5,507 | 83.9% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 49 | 56 | $17,588 | $5,395 | 30.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 86 | 135 | $27,000 | $5,380 | 19.9% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 23 | 25 | $8,050 | $4,827 | 60.0% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 19 | 59 | $10,139 | $4,601 | 45.4% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 29 | 30 | $6,840 | $4,304 | 62.9% |
| 99315 | Nursing facility discharge day management, 30 minutes or less | Facility | 2023 | 47 | 55 | $10,065 | $3,235 | 32.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 50 | 50 | $12,500 | $3,065 | 24.5% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Office | 2023 | 33 | 34 | $8,396 | $2,970 | 35.4% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 49 | 49 | $3,920 | $2,949 | 75.2% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 37 | 98 | $4,067 | $2,860 | 70.3% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 57 | 61 | $4,880 | $2,474 | 50.7% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 54 | 117 | $4,797 | $1,898 | 39.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 14 | 14 | $6,882 | $1,700 | 24.7% |
| 99235 | Initial hospital care with same-day admission and discharge with moderate level of medical decision making, per day, if using time, at least 70 minutes | Facility | 2023 | 16 | 16 | $7,232 | $1,682 | 23.3% |
About Dr. Christopher Orendorff, M.D
Dr. Christopher Orendorff, M.D is a Family Medicine healthcare provider based in Sallisaw, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/25/2009. The National Provider Identifier (NPI) number assigned to this provider is 1922233618.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Orendorff, M.D has received a total of $12,181 in payments from pharmaceutical and medical device companies, with $2,520 received in 2024. These payments were reported across 745 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($12,127).
As a Medicare-enrolled provider, Orendorff has provided services to 12,875 Medicare beneficiaries, totaling 25,709 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 144 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Sallisaw, OK
- Active Since 05/25/2009
- Last Updated 07/28/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1922233618
Products in Payments
- VRAYLAR (Drug) $1,221
- Yupelri (Drug) $734.27
- FARXIGA (Drug) $599.04
- TRELEGY ELLIPTA (Drug) $545.73
- Kerendia (Drug) $488.75
- Ozempic (Drug) $452.19
- BROVANA (Drug) $441.98
- SOLIQUA 100/33 (Biological) $429.73
- Qelbree (Drug) $428.88
- CAPLYTA (Drug) $372.64
- NURTEC ODT (Drug) $307.21
- Cologuard Collection Kit (Device) $294.94
- XARELTO (Drug) $283.69
- UBRELVY (Drug) $260.63
- Victoza (Drug) $257.43
- YUPELRI (Drug) $255.32
- Rybelsus (Drug) $248.94
- SOLIQUA (Drug) $241.13
- XIFAXAN (Drug) $232.79
- BELSOMRA (Drug) $227.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Sallisaw
Rick Robbins, D.o, D.O
Family Medicine — Payments: $543.85
Family Medicine $543.85
Rachel Grubbs, Do, DO
Family Medicine — Payments: $99.11
Family Medicine $99.11
Dr. Jennifer Scoufos, Do, DO
Family Medicine — Payments: $63.59
Family Medicine $63.59
Dr. Matthew Landeen, Do, DO
Family Medicine — Payments: $45.44
Family Medicine $45.44
Dr. James Lisonbee, Do, DO
Family Medicine
Family Medicine